What is MRNA's current stock price?

As of now, MRNA is trading at $43.29, with a daily change of +7.85%.

What are the risks associated with MRNA stock?

MRNA has Medium, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

MRNA Stock Analysis & IQ Rating | Moderna

MRNA

Moderna

$43.29

+$3.18 | +7.85%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

WallStreetBuzz 38m

Wall Street opened near the flatline after a bruising session that ended in broad-based selling. January inflation came in softer than expected, rising 0.2% month over month and 2.4% annually, reinforcing the view that price pressures are gradually cooling. That data could influe...

MRNA Stock IQ

Login to see Moderna (MRNA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

MRNA Target Price

Login to display

Strengths

MRNA Rewards

Earnings are forecast to grow

MRNA Rewards

Upgraded on attractively valued

MRNA Rewards

Trading below its fair value

MRNA Rewards

Investors confidence is positive

MRNA Price Performance

$41.84 (+3.47%)

$24.92 (+73.72%)

$26.56 (+62.99%)

$30.27 (+43.01%)

1year

6month

3month

1month

MRNA Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

MRNA Analysts Opinion

MRNA Analysts opinion is negative and it remained unchanged from the past 3 months

MRNA Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

52%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

38%

16%

100%

MRNA Street Sentiment

MRNA Street Sentiment is bullish and have positive views on the near-term outlook

MRNA Risk Level

MRNA has Medium risk level

Risks Indicators

Beta greater than 1.0

High volatilty

Medium

LOW

HIGH

MRNA Performance Sentiment

Sentiments overview associated with events and the stock performance

52%

47%

Positive

Negative

46 out of 88
events present

41 out of 88
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$40.11

Resistance
Price

$34.51

Current Price Range

$51.87

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

25%

Buy

Hold

Sell

Consensus Rating

SELL

1

3

0

Date

Action

Rating

Firm

Jan 06, 2026

Downgrade

Neutral

UBS

Nov 22, 2025

Reiterate

Overweight

Piper Sandler

Oct 24, 2025

Reiterate

Buy

UBS

Oct 23, 2025

Reiterate

Neutral

Citigroup

Oct 20, 2025

Reiterate

Hold

Needham

MRNA Latest Analysis +

Moderna GAAP EPS of -$2.11 beats by $0.49 revenue of $678M beats by $54.07M.

Today

$43.29 | +7.85%

Earnings

Earnings Snapshot: Moderna tops Q4. sees up to 10% revenue growth lower expenses in 2026.

Today

$43.29 | +7.85%

Potential

Moderna Sales Beat as Covid Shots Fall Less Than Expected. Moderna Inc. beat fourth-quarter revenue estimates as its struggling Covid vaccines business declined less than expected.

Today

$43.29 | +7.85%

Activity

Earnings

Moderna beats quarterly revenue estimates on resilient sales of COVID shot.

Today

$43.29 | +7.85%

Earnings

Moderna Reports a Narrower-Than-Expected Loss. The Stock Falls After Earnings.

Today

$43.29 | +7.85%

Momentum

Moderna: Stock to Avoid or Bad News Buy?. Key PointsModerna is working to build a seasonal vaccines portfolio to spur growth.

Thu Feb 12, 2026

$40.11 | -0.99%

Activity

FDA refuses Modernas mRNA flu vaccine application.

Thu Feb 12, 2026

$40.11 | -0.99%

Activity

Biotech Turnaround: How Moderna Went From Revenue Collapse to YTD Rally Leader. Quick Read Moderna (MRNA) gained 37% YTD through February 12th making it the 12th-best performing stock in the S&.P 500. The company reduced annual operating expenses by $2B. The FDA rejected Modernas flu vaccine filing on February 10 due to study design issues. The stock fell 8%.

Thu Feb 12, 2026

$40.11 | -0.99%

Activity

Momentum

Barclays Starts Moderna Inc. (MRNA) Neutral as Biotech Outlook Improves. We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 28 Barclays assumed coverage of Moderna Inc. (NASDAQ:MRNA) with an Equal Weight rating and a $25 price target as part of a broader biotechnology coverage expansion. The firm expressed a constructive view on the sector heading into 2026 citing [….]

Wed Feb 11, 2026

$40.51 | -3.54%

Activity

Potential

FDA Refuses To Review Modernas Application For Experimental Flu Shot. FDA Refuses To Review Moderna'.s Application For Experimental Flu Shot Authored by Troy Myers via The Epoch TimesThe Food and Drug Administration (FDA) is refusing to review Modernas experimental flu shot the company announced Tuesday.Already submitted and accepted for review in the European

Wed Feb 11, 2026

$40.51 | -3.54%

Activity

Runners Also Watch

Close Price

Change

NVAX

Novavax

8.71

+3.80%

AMGN

Amgen

368.26

+1.16%

VALN

Valneva SE

10.06

+0.40%

FAQ About MRNA Stock Insights

What is MRNA current stock price?

What are MRNA stock strengths?

What is MRNA Risk Level?

What is MRNA market cap and volume?

What is MRNA current Stock IQ?

Should I buy MRNA stock right now?

Is MRNA a Strong Buy right now?

What does a 'Strong Buy' rating mean for MRNA?

What does a 'Strong Sell' rating mean for MRNA?

What factors influence MRNA's Stock IQ?

Explore our MRNA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored MRNA Stock Strategies
Effective Risk Management

FIND US ON

Receive our MRNA Daily Alerts

Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

MRNA

Moderna

Set Alerts

Current Price

$43.29

+$3.18 | +7.85%

52W High

$55.19

MKT CAP

$17.00B

52W Low

$22.29

VOL

$3.77M

P/E Ratio

N/A

AVG VOL

$13.27M

RSI

56.41

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

NVAX

Novavax

8.71

+3.80%

AMGN

Amgen

368.26

+1.16%

VALN

Valneva SE

10.06

+0.40%

MRNA Price Performance

$41.84 (+3.47%)

$24.92 (+73.72%)

$26.56 (+62.99%)

$30.27 (+43.01%)

1year

6month

3month

1month

MRNA Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

MRNA Analysts Opinion

MRNA Analysts opinion is negative and it remained unchanged from the past 3 months

MRNA Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

52%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

38%

16%

100%

MRNA Street Sentiment

MRNA Street Sentiment is bullish and have positive views on the near-term outlook

MRNA Risk Level

MRNA has Medium risk level

Risks Indicators

Beta greater than 1.0

High volatilty

Medium

LOW

HIGH

MRNA Performance Sentiment

Sentiments overview associated with events and the stock performance.

52%

47%

Positive

Negative

46 out of 88
events present

41 out of 88
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$40.11

Resistance
Price

$34.51

Current Price Range

$51.87

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

25%

Buy

Hold

Sell

Consensus Rating

SELL

1

3

0

Date

Action

Rating

Firm

Jan 06, 2026

Downgrade

Neutral

UBS

Nov 22, 2025

Reiterate

Overweight

Piper Sandler

Oct 24, 2025

Reiterate

Buy

UBS

Oct 23, 2025

Reiterate

Neutral

Citigroup

Oct 20, 2025

Reiterate

Hold

Needham

MRNA Stock IQ

Login to unlock Moderna (MRNA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

MRNA Rewards

Earnings are forecast to grow

MRNA Rewards

Upgraded on attractively valued

MRNA Rewards

Trading below its fair value

MRNA Rewards

Investors confidence is positive

MRNA Latest Analysis

WallStreetBuzz 38m

Wall Street opened near the flatline after a bruising session that ended in broad-based selling. January inflation came in softer than expected, rising 0.2% month over month and 2.4% annually, reinforcing the view that price pressures are gradually cooling. That data could influe...

Discover MRNA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of MRNA. We're here to help you make informed investment decisions today.

FIND US ON

Receive our MRNA Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MRNA Stock trends

MRNA Stock performance

MRNA Stock analysis

MRNA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

MRNA Stock Analysis & IQ Rating | Moderna

MRNA Stock IQ

MRNA Target Price

MRNA Analysts Opinion

MRNA Street Sentiment

MRNA Risk Level

MRNA Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our MRNA Stock insights

Receive our MRNA Daily Alerts

MRNA Street Sentiment

MRNA Risk Level

Key Price Levels

Latest Analyst Actions

Discover MRNA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of MRNA. We're here to help you make informed investment decisions today.

Receive our MRNA Daily Alerts

MRNA Alerts